Stocks
Sandoz Group AGSDZNY
OTCHealthcareDrug Manufacturers - Specialty & Generic$77.77-0.73%
A global leader in generic pharmaceuticals and biosimilars, this company provides cost-effective alternatives to branded drugs across multiple therapeutic areas. Investors monitor its performance due to its significant role in improving drug affordability and its pipeline of biosimilar products.
Market Cap: $33.7B52W Range: $35.61 – $94.15
Congressional Interest in Sandoz Group AG (SDZNY)
2 members of Congress have disclosed 2 trades in Sandoz Group AG (SDZNY), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
2
Buys
0
Sells
2
Who in Congress Is Trading SDZNY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-03-24 | George Whitesides | sell | $1K – $15K |
| 2024-01-09 | John W Hickenlooper | sell | $1K – $15K |